Katelyn Kavak - Concepedia

Author

Katelyn Kavak

University at Buffalo, State University of New York ORCID

Also Known As

K. Kavak, Katelyn Kavak, Katelyn S Kavak, Katelyn S. Kavak

Publications

758

Citations

H-Index

Concepts

All Affiliations

University at Buffalo, State University of New York Jacobs Institute Multiple Sclerosis Center Of Northeastern New York University of Pennsylvania Yale University

About

Katelyn Kavak is an author at University at Buffalo, State University of New York specializing in medicine, neurology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	216
2	Public Health	3	3	68
3	Social Sciences	2	2	43
4	Epidemiology	2	2	51
5	Health Sciences	1	1	29

Katelyn Kavak

Publications

430

Citations

H-Index

Page 1

	Year	Citations
Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset Katelyn Kavak, Barbara Teter, Jesper Hagemeier, Multiple Sclerosis Journal	2014	57
Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium Caila B. Vaughn, Katelyn Kavak, Michael G. Dwyer, Multiple Sclerosis Journal	2018	43
Time interval providing highest yield for initial EEG in patients with new onset seizures Pooja Sofat, Barbara Teter, Katelyn Kavak, Epilepsy Research New Onset SeizuresNeurophysiologyEeg Signal ProcessingNeurological MonitoringCognitive Electrophysiology	2016	30
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data Samantha Epstein, Zongqi Xia, Annie Lee, Multiple Sclerosis and Related Disorders	2021	30
Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage Dejan Jakimovski, Bianca Weinstock‐Guttman, Jesper Hagemeier, Journal of the Neurological Sciences Gait AnalysisDisability MeasuresMultiple Sclerosis PatientsStroke RehabilitationNeurological Disorder	2018	29
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age Dejan Jakimovski, Katelyn Kavak, Caila B. Vaughn, Multiple Sclerosis and Related Disorders Disability Progression RegardlessMedical TreatmentAgingDisease ProgressionRehabilitation	2021	29
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk Deeya Gaindh, Katelyn Kavak, Barbara Teter, Journal of the Neurological Sciences Neuro-oncologyEpidemiologyMultiple Sclerosis PatientsCancer RiskDisease Progression	2016	28
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections Dejan Jakimovski, Karen Zakalik, Samreen Awan, Vaccines ImmunologyCovid-19Vaccine TargetCovid-19 VaccinationPublic Health	2022	23
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation Bianca Weinstock‐Guttman, Jesper Hagemeier, Katelyn Kavak, Journal of Neurology Neurosurgery & Psychiatry	2016	20
Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients Ashkan Mowla, Seyed‐Mostafa Razavi, Navdeep Lail, Journal of the Neurological Sciences ThrombosisInterventional NeuroradiologyIschemic StrokeMedicineStroke-related Condition	2021	20

Page 1